These cyclins have been shown to be associated with breast cancer progression, via modulating different cellular pathways such as by modulating VEGF and hence angiogenesis (Khaja et al., 2013[27]) and poor survival of patients (Aaltonen et al., 2009[1]; Keyomarsi et al., 2002[26]). This evidence concerns the gene PCNA and breast carcinoma.